Halozyme
HALO
160 hedge funds and large institutions have $1.49B invested in Halozyme in 2017 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 64 reducing their positions, and 25 closing their positions.
181% more call options, than puts
Call options by funds: $23.3M | Put options by funds: $8.3M
36% more capital invested
Capital invested by funds: $1.09B → $1.49B (+$398M)
3.2% more ownership
Funds ownership: 85.51% → 88.71% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
5% less funds holding
Funds holding: 168 → 160 (-8)
36% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 64
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$138M |
| 2 |
SAM
Senzar Asset Management
New York
|
+$28.6M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$27.1M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$18.4M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$13.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$10.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.46M |
| 3 |
TA
Teachers Advisors
New York
|
-$6.77M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$4.29M |
| 5 |
First Eagle Investment Management
New York
|
-$3.71M |
HALO Hedge Fund Activity: Q1 2017 in Review
160 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2017, worth a combined $1.49B — up 36% from $1.09B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of HALO and 24 opened new positions — a net loss of 1 holder — while 64 trimmed existing stakes and 41 added.
The largest buyer was BlackRock, adding an estimated $138M. The largest seller was Franklin Resources, exiting entirely with an estimated $10.2M sold.
- 160 institutional investors held Halozyme (HALO) as of Q1 2017, down from 168 in Q4 2016.
- Funds reported $1.49B of Halozyme stock for Q1 2017, up 36% quarter-over-quarter.
- 24 funds opened new Halozyme positions in Q1 2017 and 25 closed out, a net change of -1 holder.
- The largest Halozyme buyer in Q1 2017 was BlackRock, an estimated $138M added.
- The largest Halozyme seller in Q1 2017 was Franklin Resources, an estimated $10.2M sold.
Based on aggregated 13F filings for Q1 2017.